The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index; none of the 36 sources its claims cite is checked for support yet.
SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium
Open accessAbstract
Various reports indicate an association between COVID-19 and anosmia, suggesting an infection of the olfactory sensory epithelium, and thus a possible direct virus access to the brain. To test this hypothesis, we generated RNA-seq libraries from human olfactory neuroepithelia, in which we found substantial expression of the genes coding for the virus receptor angiotensin-converting enzyme-2 (ACE2), and for the virus internalization enhancer TMPRSS2. We analyzed a human olfactory single-cell RNA-seq dataset and determined that sustentacular cells, which maintain the integrity of olfactory sensory neurons, express ACE2 and TMPRSS2 . We then observed that the ACE2 protein was highly expressed in a subset of sustentacular cells in human and mouse olfactory tissues. Finally, we found ACE2 transcripts in specific brain cell types, both in mice and humans. Sustentacular cells thus represent a potential entry door for SARS-CoV-2 in a neuronal sensory system that is in direct connection with the brain.
Overview
CoChat Summary
TL;DR
Human olfactory neuroepithelium expresses SARS-CoV-2 entry genes, with ACE2 and TMPRSS2 enriched in sustentacular cells rather than olfactory sensory neurons. ACE2 transcripts/protein were also found in specific brain cell types, suggesting potential routes for infection and anosmia.
Key findings
- Bulk RNA-seq of human nasal biopsies found mean ACE2 and TMPRSS2 expression in olfactory sensory neuroepithelium (4.6 and 76.1 TPM, respectively) and respiratory epithelium (7.1 and 63.7 TPM, respectively), indicating entry-gene expression in both tissues.
- In a public single-cell RNA-seq dataset of 28,726 cells from four adult patients, sustentacular cells and respiratory ciliated cells showed the highest coexpression of ACE2 and TMPRSS2; olfactory sensory neurons showed little or no expression. ACE2-positive sustentacular cells numbered 71 versus 3,011 ACE2-negative, and ACE2-positive respiratory ciliated cells numbered 19 versus 567 ACE2-negative.
- Immunohistochemistry confirmed ACE2 protein in a subset of sustentacular cells in mouse and human olfactory tissues; in mouse, ACE2 labeling was apical and restricted to dorsal, not ventral, olfactory epithelium. TMPRSS2 labeling was observed in many nasal epithelium constituents.
- In mouse brain datasets, Ace2 was limited mainly to pericytes/mural cells and not neurons; in human brain datasets, ACE2 was found in non-neuronal and neuronal types including astrocytes, oligodendrocytes, Purkinje neurons, and cortical layer 5 neurons, with some coexpressing TMPRSS2.
Methods
- Bulk RNA-seq libraries were generated from human olfactory and respiratory nasal biopsies collected via nasal endoscopic surgery from four adult patients, followed by differential expression analysis.
- Public single-cell RNA-seq data from human olfactory/nasal tissue (Durante et al., 2020; 28,726 cells, 26 clusters) were reanalyzed for ACE2, TMPRSS2, ERMN, and GSTA2 expression and coexpression.
- Immunohistochemistry was performed on mouse and human olfactory tissues and mouse olfactory bulb using anti-ACE2 and anti-TMPRSS2 antibodies with neuronal/sustentacular markers (TUJ1, OMP, ERMN); olfactory epithelium from two deceased SARS-CoV-2-infected individuals was also examined.
Limitations
- Stated: the olfactory sensory epithelium from two deceased SARS-CoV-2-infected individuals was highly damaged and largely detached from the basal lamina, hindering identification of viral particles in sustentacular cells; whether the damage was caused by the virus could not be determined from the few samples analyzed.
- Evident from the text: sample sizes are small (four adult patients for biopsies; two deceased infected individuals), and brain expression conclusions rely partly on public datasets with possible differences in sequencing depth, protocol, mRNA half-lives, or cell-type selection.
- Evident from the text: the study does not demonstrate functional SARS-CoV-2 infection of sustentacular cells or establish causality for anosmia; the authors note that inflammation or infection of other non-neuronal cell types cannot be excluded.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
0 Valid · 0 Not valid · 24 Not checked · 52 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Congruently with its pervasiveness in the single-cell transcriptomes, TMPRSS2 labeling was observed in many constituents of the nasal epithelium (Figures 4H, S4F, and S4G).”
§ SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain > Results > ACE2 and TMPRSS2 Protein Expression in the Olfactory Neuroepithelium
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the first collection, published by Zeisel et al. (2018), which includes non-neuronal cells, we found a very limited number of cell types that expressed Ace2 (Figure 5A).”
§ SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain > Results > SARS-CoV-2 Receptor Expression in the Brain
What the sources say
- Not checked yetcites Zeisel et al. (2018)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we generated RNA-seq libraries from human olfactory neuroepithelia, in which we found substantial expression of the genes coding for the virus receptor angiotensin-converting enzyme-2 (ACE2) and for the virus internalization enhancer TMPRSS2.”
- Also stated in: § Expression of ACE2 and TMPRSS2 Human Sustentacular and Respiratory Ciliated Cells · hedged
“We found a mean of 4.6 and 76.1 TPMs in the sensory neuroepithelium samples for ACE2 and TMPRSS2, respectively (Figures 1F and 1G), indicating the presence in this tissue of cells that may express both genes, or of a mix of cells that express either TMPRSS2 or ACE2.”
§ SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain > Abstract
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § Expression of ACE2 and TMPRSS2 Human Sustentacular and Respiratory Ciliated Cells · hedged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the olfactory cavity, a strong and defined labeling was observed in the respiratory epithelium in the nasal cavity and nasopharyngeal duct (Figures S3A–S3H), and in a subset of sustentacular cells lining the nasal cavity (Figures 3C–3G and S3B).”
§ SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain > Results > ACE2 and TMPRSS2 Protein Expression in the Olfactory Neuroepithelium
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Olfactory sensory neurons showed little or no expression of TMPRSS2 and ACE2, respectively (Figure 2C).”
§ SARS-CoV-2 Receptors and Entry Genes Are Expressed in the Human Olfactory Neuroepithelium and Brain > Results > Expression of ACE2 and TMPRSS2 Human Sustentacular and Respiratory Ciliated Cells
plainn = 4- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
45 more claims
Create a free account to see all 76 claims and to verify the 36 references still open.
- It may state two separate claims as one. 15
- Probably not a substantial claim. 12
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ACE2 expression has been reported for many tissues/organs including the lung (ie, lung type II alveolar cells/AT2, bronchial epithelial cells), brain, kidney, small intestine, colon, and heart.”
From COVID-19, Myocarditis and Pericarditis (2023) · cites this paper as [15]
Experimental — accuracy not yet measuredIn the citing paper
“Studies reported that human olfactory sustentacular cells express both ACE2 and TMPRSS2 virus receptors [33].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [33]
In the citing paper
“Although current literature data reports that human olfactory sensory neurons do not express these proteins, they express CD147 that could allow SARS-CoV-2 neuroinvasion (Fig. 1) [33, 34].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [33]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Cited by
Brann, D. H., Tsukahara, T., Weinreb, C., Lipovsek, M., Van den Berge, K., Gong, B., Chance, R., Macaulay, I. C., Chou, H.-J., Fletcher, R. B., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc5801 · Cited by 1,198
IgA dominates the early neutralizing antibody response to SARS-CoV-2
Sterlin, D., Mathian, A., Miyara, M., Mohr, A., Anna, F., Claër, L., Quentric, P., Fadlallah, J., Devilliers, H., Ghillani, P., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd2223 · Cited by 1,037
Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.2065 · Cited by 923
Zhu, Z., Lian, X., Su, X., Wu, W., Marraro, G. A., & Zeng, Y. (2020) · Respiratory Research · doi:10.1186/s12931-020-01479-w · Cited by 614
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
Metadata
- Authors
- Fodoulian, L., Tuberosa, J., Rossier, D., Boillat, M., Kan, C., Pauli, V., Egervari, K., Lobrinus, J. A., Landis, B. N., Carleton, A., & Rodriguez, I.
- Affiliations
- University of Geneva (CH)
- University Hospital of Geneva (CH)
- Corresponding author
- Carleton, Alan
- ORCID
- Venue
- iScience
- Publisher
- openRxiv
- Published
- 2020-04-02
- Volume
- 23
- Issue
- 12
- Pages
- 101839-101839
- ISSN
- 2589-0042 (ISSN-L)
- PMC
- PMC7685946
- OpenAlex
- W3107452553
- Cited by
- 286
- References
- 77
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 29 · 2023: 46 · 2022: 68 · 2021: 68 · 2020: 60
- FWCI
- 21.23
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.biorxiv.org/about/FAQ#license (vor)
- Locations
- iScience (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (publishedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by-nd)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (172878, 189153)
- Université de Genève (31003A_172878, 310030_189153)
- Institute of Genetics and Genomics of Geneva
- Topics
- Life Sciences › Neuroscience › Sensory Systems › Olfactory and Sensory Function Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, olfactory epithelium, ACE2, TMPRSS2, sustentacular cells, olfactory sensory neurons, anosmia, olfactory bulb, viral entry, single-cell RNA sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium. https://app.cochat.ai/papers/10.1101/2020.03.31.013268
- The paper
- Fodoulian, L., Tuberosa, J., Rossier, D., Boillat, M., Kan, C., Pauli, V., Egervari, K., Lobrinus, J. A., Landis, B. N., Carleton, A., & Rodriguez, I. (2020). SARS-CoV-2 receptor and entry genes are expressed by sustentacular cells in the human olfactory neuroepithelium. iScience. https://doi.org/10.1101/2020.03.31.013268
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.